Carlos Agusti
- Efficacy predictors of lung volume reduction with Zephyr valves in a European cohortBy Felix J.F. Herth, Marc Noppen, Arschang Valipour, Sylvie Leroy, Jean-Michel Vergnon, Joachim H. Ficker, Jim J. Egan, Stefano Gasparini, Carlos Agusti, Debby Holmes-Higgin and Armin ErnstFelix J.F. HerthMarc NoppenArschang ValipourSylvie LeroyJean-Michel VergnonJoachim H. FickerJim J. EganStefano GaspariniCarlos AgustiDebby Holmes-Higgin
- Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPDBy Néstor Soler, Mariano Esperatti, Santiago Ewig, Arturo Huerta, Carlos Agustí and Antoni TorresNéstor Soler*Pneumology Dept, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain¶Both authors contributed equallyMariano Esperatti*Pneumology Dept, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain¶Both authors contributed equallySantiago Ewig#Thoraxzentrum Ruhrgebiet, Department of Respiratory and Infectious Diseases, EVK Herne and Augusta-Kranken-Anstalt Bochum, Bochum, GermanyArturo Huerta*Pneumology Dept, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, SpainCarlos Agustí*Pneumology Dept, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, SpainAntoni Torres*Pneumology Dept, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
- Inhaled corticosteroids (ICS), systemic inflammatory response and mortality in community-acquired pneumonia (CAP)By Miquel Ferrer, Antoni Torres, Soledad Reyes, Raquel Martinez, Paula Ramirez, Eva Polverino, Carlos Agusti, Juan Cordoba and Rosario MenendezMiquel Ferrer1Servei de Pneumologia, Hospital Clinic, Barcelona, SpainAntoni Torres1Servei de Pneumologia, Hospital Clinic, Barcelona, SpainSoledad Reyes2Servicio de Neumología, Hospital Universitario la Fe, Valencia, SpainRaquel Martinez2Servicio de Neumología, Hospital Universitario la Fe, Valencia, SpainPaula Ramirez3Unidad de Cuidados Intensivos, Hospital Universitario la Fe, Valencia, SpainEva Polverino1Servei de Pneumologia, Hospital Clinic, Barcelona, SpainCarlos Agusti1Servei de Pneumologia, Hospital Clinic, Barcelona, SpainJuan Cordoba4Servicio de Microbiología, Hospital Universitario la Fe, Valencia, SpainRosario Menendez2Servicio de Neumología, Hospital Universitario la Fe, Valencia, Spain
- Lung function abnormalities in patients with heart failure and preserved ejection fractionBy Alejandra Lopez-Giraldo, Rut Andrea, Patricia Sobradillo, Carlos Falces, Laura Sanchis, Concepcion Gistau, Magda Heras, Josep Brugada and Alvar AgustiAlejandra Lopez-Giraldo1Pneumology, Thorax Institute, Hospital Clinic, Barcelona, SpainRut Andrea2Cardiology, Thorax Institute, Hospital Clinic, Barcelona, SpainPatricia Sobradillo1Pneumology, Thorax Institute, Hospital Clinic, Barcelona, SpainCarlos Falces2Cardiology, Thorax Institute, Hospital Clinic, Barcelona, SpainLaura Sanchis2Cardiology, Thorax Institute, Hospital Clinic, Barcelona, SpainConcepcion Gistau1Pneumology, Thorax Institute, Hospital Clinic, Barcelona, SpainMagda Heras2Cardiology, Thorax Institute, Hospital Clinic, Barcelona, SpainJosep Brugada2Cardiology, Thorax Institute, Hospital Clinic, Barcelona, SpainAlvar Agusti1Pneumology, Thorax Institute, Hospital Clinic, Barcelona, Spain
- Utility of biomarkers in the management of respiratory diseases in hematopoietic stem cell transplantBy Carmen Mª Lucena, Montserrat Rovira, Xavier Filella, Rebeca Domingo, Antoni Torres and Carlos AgustíCarmen Mª Lucena1Respiratory, Hospital Clínic, Barcelona, SpainMontserrat Rovira2Hematology, Hospital Clínic, Barcelona, SpainXavier Filella3Biochemical, Hospital Clínic, Barcelona, SpainRebeca Domingo1Respiratory, Hospital Clínic, Barcelona, SpainAntoni Torres1Respiratory, Hospital Clínic, Barcelona, SpainCarlos Agustí1Respiratory, Hospital Clínic, Barcelona, Spain
- Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPDBy Néstor Soler, Mariano Esperatti, Santiago Ewig, Arturo Huerta, Carlos Agustí and Antoni TorresArticle | Published in 2012 in European Respiratory JournalNéstor SolerMariano EsperattiSantiago EwigArturo HuertaCarlos AgustíAntoni Torres
- Prognostic value and functional characterization of miR-141 and miR-200c expression levels in resected NSCLBy Jorge Moisés, Ramon Marrades, Rut Tejero, Alfons Navarro, Marc Campayo, Nuria Viñolas, Carlos Agustí, Adela Saco, Marina Paradela, Laureano Molins, José Ramirez and Mariano MonzóJorge Moisés1Pneumology, Hospital Clínic, Barcelona, SpainRamon Marrades1Pneumology, Hospital Clínic, Barcelona, SpainRut Tejero2Facultat de Medicina, Universitat de Barcelona, Barcelona, SpainAlfons Navarro2Facultat de Medicina, Universitat de Barcelona, Barcelona, SpainMarc Campayo3Oncology, Hospital Clínic, Barcelona, SpainNuria Viñolas3Oncology, Hospital Clínic, Barcelona, SpainCarlos Agustí1Pneumology, Hospital Clínic, Barcelona, SpainAdela Saco4Pathology, Hospital Clínic, Barcelona, SpainMarina Paradela5Thoracic Surgery, Hospital Clínic, Barcelona, SpainLaureano Molins5Thoracic Surgery, Hospital Clínic, Barcelona, SpainJosé Ramirez4Pathology, Hospital Clínic, Barcelona, SpainMariano Monzó2Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
- Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trialBy Antoni Torres, Oriol Sibila, Miquel Ferrer, Rosario Mendendez, Josep Mensa, Albert Gabarrus, Jacobo Sellares, Marcos Restrepo, Antonio Anzueto, Nichael Niederman, Carlos Agusti and Eva PolverinoAntoni Torres1Respiratory Disease Department, Hospital Clinic, Barcelona, SpainOriol Sibila2Respiratory Disease Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainMiquel Ferrer1Respiratory Disease Department, Hospital Clinic, Barcelona, SpainRosario Mendendez3Respiratory Disease Department, Hospital La Fe, Valencia, SpainJosep Mensa4Infectious Disease Department, Hospital Clinic, Barcelona, SpainAlbert Gabarrus1Respiratory Disease Department, Hospital Clinic, Barcelona, SpainJacobo Sellares1Respiratory Disease Department, Hospital Clinic, Barcelona, SpainMarcos Restrepo5University of Texas, Health Science Center, San Antonio, TX United StatesAntonio Anzueto5University of Texas, Health Science Center, San Antonio, TX United StatesNichael Niederman6Winthrop-University Hospital, Mineola, Winthrop-University Hospital, Mineola, New York, United StatesCarlos Agusti1Respiratory Disease Department, Hospital Clinic, Barcelona, SpainEva Polverino1Respiratory Disease Department, Hospital Clinic, Barcelona, Spain
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.